人类免疫缺陷病毒1型、丙型肝炎病毒和乙型肝炎病毒的传染性及输血传播风险。 - Suppr

Suppr

超能文献

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.

作者信息

Kleinman Steven H, Lelie Nico, Busch Michael P

机构信息

University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Transfusion. 2009 Nov;49(11):2454-89. doi: 10.1111/j.1537-2995.2009.02322.x. Epub 2009 Jul 21.

DOI:10.1111/j.1537-2995.2009.02322.x

PMID:19682345

Abstract

摘要

相似文献

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.人类免疫缺陷病毒1型、丙型肝炎病毒和乙型肝炎病毒的传染性及输血传播风险。

Transfusion. 2009 Nov;49(11):2454-89. doi: 10.1111/j.1537-2995.2009.02322.x. Epub 2009 Jul 21.

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.输血传播人类免疫缺陷病毒、乙型肝炎病毒、丙型肝炎病毒和人类嗜T淋巴细胞病毒的残余风险。

Intern Med J. 2005 Oct;35(10):592-8. doi: 10.1111/j.1445-5994.2005.00926.x.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.个体捐赠核酸检测对南非输血传播人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒风险的影响。

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.意大利输血传播人类免疫缺陷病毒、丙型肝炎病毒和乙型肝炎病毒感染的残余风险

Transfusion. 2005 Oct;45(10):1670-5. doi: 10.1111/j.1537-2995.2005.00576.x.

[Viral safety of blood and blood products].[血液及血液制品的病毒安全性]

Fortschr Med. 1993 Nov 30;111(33):526-7.

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.核酸检测对意大利乙型肝炎病毒、丙型肝炎病毒和人类免疫缺陷病毒血液供应安全性的影响：一项为期6年的调查。

Transfusion. 2008 Oct;48(10):2205-13. doi: 10.1111/j.1537-2995.2008.01813.x. Epub 2008 Jul 8.

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.发病率/窗口期模型及其在评估输血传播人类免疫缺陷病毒和丙型肝炎病毒感染风险中的应用。

Transfus Med Rev. 1997 Jul;11(3):155-72. doi: 10.1053/tmrv.1997.0110155.

[Transfusion-induced virus infections: how great is the risk?].[输血导致的病毒感染：风险有多大？]

Infusionsther Transfusionsmed. 1993 Jun;20 Suppl 2:4-9.

[Nosocomial hepatitis B virus, hepatitis C virus and HIV infections by infectious medial personnel].[感染性医疗人员的医院获得性乙型肝炎病毒、丙型肝炎病毒和艾滋病毒感染]

Gesundheitswesen. 1998 Oct;60(10):545-51.

Current issues in blood component therapy: transmission of infectious diseases.血液成分治疗中的当前问题：传染病的传播

Oncology (Williston Park). 1987 Jun;1(4):21-30.

引用本文的文献

The first case of transfusion-transmitted hepatitis B virus genotype I in Japan.日本首例输血传播的乙型肝炎病毒基因I型感染病例。

Transfusion. 2025 Apr;65(4):773-778. doi: 10.1111/trf.18186. Epub 2025 Mar 2.

Transmitted blood infections and emerging vector-borne diseases in blood donors in northern Portugal.葡萄牙北部献血者中的输血传播血液感染及新出现的媒介传播疾病。

Hematol Transfus Cell Ther. 2025 Jan-Mar;47(1):103734. doi: 10.1016/j.htct.2025.103734. Epub 2025 Feb 8.

Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China.中国南方地区献血者乙型肝炎病毒血清学和核酸检测的成本效益分析。

BMC Infect Dis. 2024 Sep 2;24(1):909. doi: 10.1186/s12879-024-09786-z.

A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies.乙型肝炎病毒感染、丁型肝炎病毒、肝细胞癌及新兴疗法的全身表现综述

Gastro Hep Adv. 2023 Jul 17;3(2):276-291. doi: 10.1016/j.gastha.2023.06.014. eCollection 2024.

Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases.利用供体人群研究输血传播和新发传染病的流行病学和发病机制。

Transfus Med Rev. 2023 Oct;37(4):150769. doi: 10.1016/j.tmrv.2023.150769. Epub 2023 Oct 4.

Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies.输血医学中新型病原体的威胁：利用病原体灭活技术提高安全性与可信度

Pathogens. 2023 Jul 5;12(7):911. doi: 10.3390/pathogens12070911.

Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations.是否有必要对丙型肝炎进行双重检测？模拟澳大利亚献血中去除丙型肝炎抗体检测的风险。

Vox Sang. 2023 Jun;118(6):480-487. doi: 10.1111/vox.13430. Epub 2023 May 14.

Newly diagnosed hepatitis C infection after pancreas transplantation with multiple treatment failures.胰腺移植后多次治疗失败导致新发丙型肝炎感染。

BMJ Case Rep. 2023 May 3;16(5):e254331. doi: 10.1136/bcr-2022-254331.

Recommendations for the establishment and operation of a donor human milk bank.建立和运营人类捐赠母乳库的建议。

Nutr Rev. 2023 Mar 9;81(Suppl 1):1-28. doi: 10.1093/nutrit/nuad012.

Insights on 21 Years of HBV Surveillance in Blood Donors in France.法国 21 年来对献血者乙型肝炎病毒监测的见解。

Viruses. 2022 Nov 12;14(11):2507. doi: 10.3390/v14112507.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验